Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

NCT04388215 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemias

Interventions

DRUG: CKD-828
DRUG: CKD-828(placebo)
DRUG: D326
DRUG: D326(placebo)
DRUG: D337
DRUG: D337(placebo)
DRUG: D013
DRUG: D013(placebo)

Sponsor

Chong Kun Dang Pharmaceutical